Summit Therapeutics

Summit Therapeutics

Director, Value Outcomes Liaison (VOL)

Remote (US) · Director

Sponsorship not specified$190k-$237kDetected 58 days ago
Data AnalysisContent MarketingRecruitingClinical TrialsResearchExperimental DesignCommunicationCollaboration

Stay score

odds of building a lasting career here

59Sponsors, lottery-bound
Cap-exempt (no lottery)0
Sponsors this role80
Entry-level history0
PERM / green-card track0
Lottery odds (Level IV)94
Fits your clock70

Sponsors, but it's cap-subject — you still face the weighted lottery (~61% per draw at Level IV). Good if you win; have a cap-exempt backup on your list.

Lottery odds assume a STEM candidate.

Personalize to your clock →

Employer immigration record

from this employer's Department of Labor filings

Files H-1B transfers

4 transfer filings in the last year, covering 4 workers. Median labor-condition decision: 7 days. An employer that already files transfers is one that can take over an existing H-1B.

Sourced from Department of Labor LCA, PERM and prevailing-wage disclosure data. Employer matching is by name, so figures may be split across an employer's legal entities. Absence of a filing means none appears in our copy of the data, not that none exists.

Community outcomes

No reports yet — be the first to help the next applicant.

About the role

  • The Director, VOL is a critical member of an expanding team, responsible for interfacing with US population-based decision makers (PBDMs) including payers, health systems, clinical pathway organizations, P&T committees, and policy makers.
  • The VOL educates key stakeholders on clinical, economic, and humanistic impact of ivonescimab to help inform formulary access, pathway/guideline decisions, and improve lives of cancer patients.
  • Serve as a conduit and resource for providing clinical and healthcare economic information (HCEI) to payers and formulary decision-makers

Responsibilities

  • Independently cultivate and manage relationships with PBDMs, acting as primary point of contact and collaborating closely with other field roles to ensure an aligned approach to stakeholder engagement
  • Collaborate with internal HEOR team and market access team, to execute on scientific engagement strategy for appropriate stakeholders (e.g., Payers, PBMs, GPOs, IDNs and Oncology Pathways) within a territory or customer base
  • Understanding of principles of study design, methodology, data analysis, and interpretation to successfully communicate data to stakeholders
  • Ability to work collaboratively across diverse teams and manage multiple stakeholders with ability to influence and collaborate to make a business impact

Requirements

  • Maintaining required knowledge of ivonescimab, to proactively and reactively communicate clinical and economic information related to ivonescimab to advance formulary decision-making and improve patient outcomes
  • All employment businesses/agencies are required to contact Summit's Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit.
  • Strong analytical capabilities and excellent communication skills, including ability to communicate large amounts of scientific information in a manner that is clear, concise and memorable
  • Ability to be proactive, enthusiastic and goal oriented

Nice to have

  • Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people.
  • Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology.
  • Summit has multiple global Phase 3 clinical studies, including:
  • Non-small Cell Lung Cancer (NSCLC)
  • Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.
  • Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.
  • Colorectal Cancer (CRC)
  • Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.

Compensation

  • $190,000 - $237,000 USD
  • Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location.
  • The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.

Benefits

  • MD, PharmD, or PhD in Health Services Research, Health Economics, or related field
  • Minimum of 12+ years relevant experience in healthcare industry with minimum 5+ years direct experience in the pharmaceutical, managed care, or consulting industries
  • Previous experience in field-based role with strong understanding of the US healthcare system, market access landscape and value-based decision makers
  • Experience analyzing health care data and utilizing real-world evidence (RWE) is a plus
  • Understand the medical affairs priorities to contribute to content strategy development and execute aligned field tactics
  • Collaborate effectively with medical affairs, HEOR, market access and other colleagues as appropriate in support of developing and implementing account engagement plan, providing input on scientific and value topics

Company info

  • Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.
  • Summit Therapeutics is seeking a Director, Value Outcomes Liaison (VOL), to join our mission of developing Ivonescimab, a novel and unique immunotherapy with the potential to help patients suffering from life-threatening cancers.

Equal opportunity

  • Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment.
Apply directly at Summit Therapeutics →Create a free account for alerts like thisView Summit Therapeutics immigration profile

This listing is sourced directly from Summit Therapeutics's careers page and normalized into a canonical job model.